Form 8-K - Current report:
SEC Accession No. 0001420720-24-000029
Filing Date
2024-07-09
Accepted
2024-07-09 16:02:13
Documents
22
Period of Report
2024-07-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ibio-20240702x8k.htm   iXBRL 8-K 45075
2 EX-10.1 ibio-20240702xex10d1.htm EX-10.1 80286
3 EX-10.2 ibio-20240702xex10d2.htm EX-10.2 77707
4 EX-10.3 ibio-20240702xex10d3.htm EX-10.3 85970
5 EX-10.4 ibio-20240702xex10d4.htm EX-10.4 104649
6 EX-10.5 ibio-20240702xex10d5.htm EX-10.5 65304
7 EX-10.6 ibio-20240702xex10d6.htm EX-10.6 96982
8 EX-10.7 ibio-20240702xex10d7.htm EX-10.7 99261
9 EX-14.1 ibio-20240702xex14d1.htm EX-14.1 44744
  Complete submission text file 0001420720-24-000029.txt   949092

Data Files

Seq Description Document Type Size
10 EX-101.SCH ibio-20240702.xsd EX-101.SCH 4157
11 EX-101.DEF ibio-20240702_def.xml EX-101.DEF 3988
12 EX-101.LAB ibio-20240702_lab.xml EX-101.LAB 14529
13 EX-101.PRE ibio-20240702_pre.xml EX-101.PRE 10728
24 EXTRACTED XBRL INSTANCE DOCUMENT ibio-20240702x8k_htm.xml XML 4777
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35023 | Film No.: 241107483
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)